Premise:
There is a need for alternative dose-finding methods since all reasonable regimens cannot be studied using the current standard of a 48 week controlled study of efficacy and safety
- Patient resources are limited
- Time requirements would be excessive, and delay patient access to alternative regimens
- HIV therapeutics is a fast-moving field, and approved regimens may not be acceptable as controls to patients or investigators